191 related articles for article (PubMed ID: 4586970)
1. [Amantadine and dexetimide in the treatment of parkinsonism].
Hakkarainen H; Viukari M
Duodecim; 1973 Jul; 89(21):1437-41. PubMed ID: 4586970
[No Abstract] [Full Text] [Related]
2. [Experience in the prolonged use of midantan (amantadine hydrochloride) in parkinsonism].
Man'kovskii NB; Vainshtok AB; Oleinik LI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):524-30. PubMed ID: 4705407
[No Abstract] [Full Text] [Related]
3. Amantadine hydrochloride in treatment of Parkinsonism.
Nagaswami S; Nagaswami R
Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280
[No Abstract] [Full Text] [Related]
4. [Modification of Parkinson tremor by budipine. A comparative study with amantadine].
Iizuka J; Fischer R
Nervenarzt; 1986 Mar; 57(3):184-6. PubMed ID: 3515215
[No Abstract] [Full Text] [Related]
5. [Treatment of Parkinson's disease with amantadine].
Sigwald J; Raymondeaud C; Grégoire J
Therapeutique; 1972 Nov; 48(9):555-60. PubMed ID: 4568230
[No Abstract] [Full Text] [Related]
6. Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action.
Huygens H; Vereecken JL; Tanghe A
Psychiatr Neurol Neurochir; 1973; 76(4):251-9. PubMed ID: 4581374
[No Abstract] [Full Text] [Related]
7. [Treatment of parkinsonism with viregyt (amantadine)].
Pryszmont M; Jankowicz E; Eljasz L; Slizewski M; Wiśniewska Z
Wiad Lek; 1974 Aug; 27(15):1371-5. PubMed ID: 4418066
[No Abstract] [Full Text] [Related]
8. [Efficacy of amantadine sulfate as a infusion solution in the treatment of parkinsonian syndrome].
Muschard F; Völler GW
Med Welt; 1973 Feb; 24(5):183-4. PubMed ID: 4617092
[No Abstract] [Full Text] [Related]
9. [Therapeutic experiences with amantadine sulfate as a monotherapeutic drug in patients with Parkinsonism].
Völler GW; Deze J
Z Allgemeinmed; 1973 May; 49(14):664-70. PubMed ID: 4585272
[No Abstract] [Full Text] [Related]
10. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
Schwab RS; England AC
Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453
[No Abstract] [Full Text] [Related]
11. L-dopa and amantadine in the therapy of parkinsonism.
Weeth JB; Shealy CN; Mercier DA
Wis Med J; 1969 Nov; 68(11):325-8. PubMed ID: 4901055
[No Abstract] [Full Text] [Related]
12. [Amantadine treatment in parkinsonism].
Holmsen R
Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2118-9. PubMed ID: 4773984
[No Abstract] [Full Text] [Related]
13. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
Gerstenbrand F; Grünberger J; Oberhummer I
Wien Med Wochenschr; 1971 May; 121(19):390-7. PubMed ID: 5559920
[No Abstract] [Full Text] [Related]
14. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
Gerstenbrand F; Grünberger J; Oberhummer I
HNO; 1970 Nov; 18(11):390-7. PubMed ID: 5512006
[No Abstract] [Full Text] [Related]
15. Amantadine hydrochloride in the treatment of Parkinsonism. A controlled trial.
Appleton DB; Eadie MJ; Sutherland JM
Med J Aust; 1970 Oct; 2(14):626-9. PubMed ID: 4920572
[No Abstract] [Full Text] [Related]
16. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes].
Kiseleva AM; Zlydnikov DM; Mazhinskaia VP; Lebedeva VK; Zakharova NG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):530-4. PubMed ID: 4705408
[No Abstract] [Full Text] [Related]
17. The treatment with L-dopa and amantadine in Parkinson's disease.
Pendefunda G; Pollingher B; Stefanache F; Gavril A; Oprisan C; Merling M; Nemteanu E; Ciunru M; Koropitzer I
Ther Hung; 1975; 23(1):12-6. PubMed ID: 1105871
[No Abstract] [Full Text] [Related]
18. Dexetimide: an effective drug for the control of extrapyramidal symptoms induced by pipothiazine palmitate.
Dom R; Van Lommel R; Baro F
Acta Psychiatr Scand; 1973; 49(5):563-9. PubMed ID: 4148581
[No Abstract] [Full Text] [Related]
19. Controlled trial of amantadine hydrochloride in Parkinson's disease.
Jorgensen PB; Bergin JD; Haas L; Cuningham JA; Morah DD; Pollock M; Robinson RG; Spears GF
N Z Med J; 1971 May; 73(468):263-7. PubMed ID: 4932146
[No Abstract] [Full Text] [Related]
20. [Clinical trial of the therapeutic effect of Amantadine-HCL in Parkinson's Disease].
Hacohen H; Gurtner B
Schweiz Med Wochenschr; 1972 Apr; 102(16):583-6. PubMed ID: 5019377
[No Abstract] [Full Text] [Related]
[Next] [New Search]
